DSGN
Price
$9.16
Change
-$0.64 (-6.53%)
Updated
Jan 15, 11:22 AM (EDT)
Capitalization
558.24M
61 days until earnings call
Intraday BUY SELL Signals
IDYA
Price
$36.17
Change
-$0.86 (-2.32%)
Updated
Jan 15, 11:38 AM (EDT)
Capitalization
3.25B
75 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs IDYA

Header iconDSGN vs IDYA Comparison
Open Charts DSGN vs IDYABanner chart's image
Design Therapeutics
Price$9.16
Change-$0.64 (-6.53%)
Volume$100
Capitalization558.24M
IDEAYA Biosciences
Price$36.17
Change-$0.86 (-2.32%)
Volume$200
Capitalization3.25B
DSGN vs IDYA Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. IDYA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (DSGN: $9.80 vs. IDYA: $37.03)
Brand notoriety: DSGN and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 27% vs. IDYA: 164%
Market capitalization -- DSGN: $558.24M vs. IDYA: $3.25B
DSGN [@Biotechnology] is valued at $558.24M. IDYA’s [@Biotechnology] market capitalization is $3.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 2 TA indicator(s) are bullish while IDYA’s TA Score has 4 bullish TA indicator(s).

  • DSGN’s TA Score: 2 bullish, 5 bearish.
  • IDYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а -0.71% price change this week, while IDYA (@Biotechnology) price change was -2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

IDYA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($3.25B) has a higher market cap than DSGN($558M). IDYA YTD gains are higher at: 7.116 vs. DSGN (4.478). DSGN has higher annual earnings (EBITDA): -77.38M vs. IDYA (-204.84M). IDYA has more cash in the bank: 787M vs. DSGN (206M). DSGN has less debt than IDYA: DSGN (1.74M) vs IDYA (27.2M). IDYA has higher revenues than DSGN: IDYA (215M) vs DSGN (0).
DSGNIDYADSGN / IDYA
Capitalization558M3.25B17%
EBITDA-77.38M-204.84M38%
Gain YTD4.4787.11663%
P/E RatioN/AN/A-
Revenue0215M-
Total Cash206M787M26%
Total Debt1.74M27.2M6%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNIDYA
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 1 day ago
65%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 3 days ago
75%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMDAX20.680.09
+0.44%
Principal Small-MidCap Dividend Inc A
OAYBX39.680.13
+0.33%
Oakmark Equity and Income Advisor
WHGIX13.200.03
+0.23%
Westwood Income Opportunity Instl
FHEAX15.01N/A
N/A
Fidelity Advisor Real Estate A
SUTCX3.88-0.01
-0.26%
AB Sustainable US Thematic C

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+2.40%
IDYA - DSGN
51%
Loosely correlated
+5.53%
DYN - DSGN
50%
Loosely correlated
+2.41%
SLDB - DSGN
49%
Loosely correlated
+12.60%
AURA - DSGN
48%
Loosely correlated
+3.95%
RGNX - DSGN
48%
Loosely correlated
-0.66%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+5.53%
NUVL - IDYA
59%
Loosely correlated
+6.59%
XNCR - IDYA
58%
Loosely correlated
+3.66%
XENE - IDYA
57%
Loosely correlated
+3.02%
DYN - IDYA
55%
Loosely correlated
+2.41%
VIR - IDYA
55%
Loosely correlated
+8.08%
More